These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29274441)

  • 41. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.
    Ota T; Aihara M; Saeki T; Narumiya S; Araie M
    Br J Ophthalmol; 2007 May; 91(5):673-6. PubMed ID: 17124244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
    Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IOP-lowering effect of isoquinoline-5-sulfonamide compounds in ocular normotensive monkeys.
    Sumi K; Inoue Y; Nishio M; Naito Y; Hosoya T; Suzuki M; Hidaka H
    Bioorg Med Chem Lett; 2014 Feb; 24(3):831-4. PubMed ID: 24412071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraocular pressure changes in the contralateral eye after trabeculectomy with mitomycin C.
    Vysniauskiene I; Shaarawy T; Flammer J; Haefliger IO
    Br J Ophthalmol; 2005 Jul; 89(7):809-11. PubMed ID: 15965155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocular trial of intraocular pressure-lowering medication: a prospective study.
    King AJ; Uppal S; Rotchford AP; Lakshumanan A; Abedin A; Henry E
    Ophthalmology; 2011 Nov; 118(11):2190-5. PubMed ID: 21724262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study on the combined effects of bunazosin and nipradilol or timolol on intraocular pressure in normotensive rabbits.
    Orihashi M; Shima Y; Tsuneki H; Kimura I
    Jpn J Ophthalmol; 2005; 49(6):523-526. PubMed ID: 16365801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the intraocular pressure-lowering activity of bicyclic derivatives of 1-substituted benzyloctahydroisoquinoline.
    Saha SL; Igbo IN; Opere CA; Zhan GL; Taniyama J; Ohia SE; Roche VF
    J Ocul Pharmacol Ther; 2001 Oct; 17(5):413-20. PubMed ID: 11765146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
    Yamane S; Karakawa T; Nakayama S; Nagai K; Moriyuki K; Neki S; Suto F; Kambe T; Hirota Y; Kawabata K
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2547-52. PubMed ID: 25788650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
    Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
    Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys.
    Kurashima H; Asai Y; Aihara M; Ishida N; Nakamura M; Araie M
    J Glaucoma; 2012 Feb; 21(2):123-8. PubMed ID: 21423041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
    Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
    Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
    Bonomi L; Perfetti S; Bellucci R; De Franco I
    J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
    Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
    Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
    Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WK; Prasanna G; Chiroli V; Ongini E; Krauss AH
    Exp Eye Res; 2011 Sep; 93(3):243-9. PubMed ID: 21356209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.